These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 6781802

  • 1. Inhibition of immune precipitation by complement.
    Schifferli JA, Bartolotti SR, Peters DK.
    Clin Exp Immunol; 1980 Nov; 42(2):387-94. PubMed ID: 6781802
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of immune precipitation by complement.
    Hong K, Takata Y, Sayama K, Kozono H, Takeda J, Nakano Y, Kinoshita T, Inoue K.
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [Abstract] [Full Text] [Related]

  • 3. Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways.
    Schifferli JA, Woo P, Peters DK.
    Clin Exp Immunol; 1982 Mar; 47(3):555-62. PubMed ID: 6979442
    [Abstract] [Full Text] [Related]

  • 4. The role of C1, C1-inactivator and C4 in modulating immune precipitation.
    Schifferli JA, Steiger G, Schapira M.
    Clin Exp Immunol; 1985 Jun; 60(3):605-12. PubMed ID: 4017288
    [Abstract] [Full Text] [Related]

  • 5. Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemia.
    Corvetta A, Spaeth PJ, Ghirelli PA, Orecchioni F, Buetler R, Montroni M, Nydegger UE.
    Diagn Immunol; 1983 Jun; 1(4):315-23. PubMed ID: 6333960
    [Abstract] [Full Text] [Related]

  • 6. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
    Schifferli JA, Steiger G, Paccaud JP.
    Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
    Kievits F, Kijlstra A.
    Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
    [Abstract] [Full Text] [Related]

  • 8. Clearance kinetics and organ uptake of complement-solubilized immune complexes in mice.
    Aguado MT, Mannik M.
    Immunology; 1987 Feb; 60(2):255-60. PubMed ID: 3817872
    [Abstract] [Full Text] [Related]

  • 9. Prevention of immune precipitation by purified components of the alternative pathway.
    Naama JK, Holme E, Hamilton E, Whaley K.
    Clin Exp Immunol; 1985 Apr; 60(1):169-77. PubMed ID: 3159522
    [Abstract] [Full Text] [Related]

  • 10. Activation of rat complement by soluble and insoluble rat IgA immune complexes.
    Rits M, Hiemstra PS, Bazin H, Van Es LA, Vaerman JP, Daha MR.
    Eur J Immunol; 1988 Dec; 18(12):1873-80. PubMed ID: 3220102
    [Abstract] [Full Text] [Related]

  • 11. Fc-mediated immune precipitation. II. Analysis of precipitating immune complexes by rate-zonal ultracentrifugation.
    Møller NP, Steensgaard J.
    Immunology; 1979 Nov; 38(3):641-8. PubMed ID: 521056
    [Abstract] [Full Text] [Related]

  • 12. Prevention of immune precipitation by purified classical pathway complement components.
    Naama JK, Hamilton AO, Yeung-Laiwah AC, Whaley K.
    Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
    [Abstract] [Full Text] [Related]

  • 13. Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitates.
    Takata Y, Tamura N, Fujita T.
    J Immunol; 1984 May; 132(5):2531-7. PubMed ID: 6232320
    [Abstract] [Full Text] [Related]

  • 14. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
    Kilgallon W, Amlot PL, Williams BD.
    Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
    [Abstract] [Full Text] [Related]

  • 15. Effect of soluble immune complexes of Fc and C3 receptor-dependent phagocytosis by human monocytes.
    Kávai M, Sándor M, Szegedi G, Füst G, Gergely J.
    Immunology; 1981 Nov; 44(3):599-606. PubMed ID: 7033117
    [Abstract] [Full Text] [Related]

  • 16. Delayed removal of renal-bound antigen in decomplemented rabbits with acute serum sickness.
    Bartolotti SR, Peters DK.
    Clin Exp Immunol; 1978 May; 32(2):199-206. PubMed ID: 352585
    [Abstract] [Full Text] [Related]

  • 17. The influence of classical pathway components during alternative pathway--modulated immune complex aggregation: the role of C1 INH.
    Gronski P, Bodenbender L, Kanzy EJ, Seiler FR.
    Behring Inst Mitt; 1984 Nov; (76):29-41. PubMed ID: 6335396
    [Abstract] [Full Text] [Related]

  • 18. Sheep serum complement sensitisation of sheep erythrocyte-rabbit antibody complexes for haemolysis by guinea-pig complement plus EDTA or Mg2+-EGTA.
    Jonas W, Stankiewicz M.
    Arch Immunol Ther Exp (Warsz); 1986 Nov; 34(4):451-60. PubMed ID: 3099725
    [Abstract] [Full Text] [Related]

  • 19. Immune adherence and staphylococcus protein A binding of soluble immune complexes produced by complement activation.
    Schifferli JA, Peters DK.
    Clin Exp Immunol; 1983 Dec; 54(3):827-33. PubMed ID: 6228359
    [Abstract] [Full Text] [Related]

  • 20. BSA-anti-BSA immune complexes formed in the presence of human complement do not bind to autologous red blood cells.
    Varga L, Thiry E, Füst G.
    Immunology; 1988 Jul; 64(3):381-4. PubMed ID: 3410490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.